These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 22251223)
1. Unusual case of severe late-onset cytomegalovirus-induced hemorrhagic cystitis and ureteritis in a renal transplant patient. Ersan S; Yorukoglu K; Sert M; Atila K; Celik A; Gulcu A; Cavdar C; Sifil A; Bora S; Gulay H; Camsari T Ren Fail; 2012; 34(2):247-50. PubMed ID: 22251223 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of viral infections and hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Shakiba E; Yaghobi R; Ramzi M Exp Clin Transplant; 2011 Dec; 9(6):405-12. PubMed ID: 22142049 [TBL] [Abstract][Full Text] [Related]
3. CMV reactivation induced BK virus-associated late onset hemorrhagic cystitis after peripheral blood stem cell transplantation. Bielorai B; Shulman LM; Rechavi G; Toren A Bone Marrow Transplant; 2001 Sep; 28(6):613-4. PubMed ID: 11607776 [TBL] [Abstract][Full Text] [Related]
4. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790 [TBL] [Abstract][Full Text] [Related]
5. Late cytomegalovirus disease following liver transplantation. Shibolet O; Ilan Y; Kalish Y; Safadi R; Ashur Y; Eid A; Shouval D; Wolf D Transpl Int; 2003 Dec; 16(12):861-5. PubMed ID: 12904846 [TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies. Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495 [TBL] [Abstract][Full Text] [Related]
7. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease. Xu LP; Zhang HY; Huang XJ; Liu KY; Liu DH; Han W; Chen H; Chen YH; Gao ZY; Zhang YC; Lu DP Chin Med J (Engl); 2007 Oct; 120(19):1666-71. PubMed ID: 17935666 [TBL] [Abstract][Full Text] [Related]
8. Late and atypical cytomegalovirus disease in solid-organ transplant recipients. Slifkin M; Tempesti P; Poutsiaka DD; Snydman DR Clin Infect Dis; 2001 Oct; 33(7):E62-8. PubMed ID: 11528587 [TBL] [Abstract][Full Text] [Related]
9. Four cases of CMV ureteritis: emergence of a new pattern of disease? Thomas MC; Russ GR; Mathew TH; Rao Mohan M; Cooper J; Walker RJ Clin Transplant; 2001 Oct; 15(5):354-8. PubMed ID: 11678963 [TBL] [Abstract][Full Text] [Related]
10. [Ureterostomy cytomegalovirus infection presenting as stoma ulceration in a kidney allograft receptor: a case report]. Rico JE; Cardona X; Rodelo J; Reino A; Arias LF; Arbeláez M Actas Urol Esp; 2008 Jun; 32(6):649-52. PubMed ID: 18655351 [TBL] [Abstract][Full Text] [Related]
11. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis. Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021 [TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation. Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L; Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546 [TBL] [Abstract][Full Text] [Related]
13. CMV and BKV ureteritis: which prognosis for the renal graft? Fusaro F; Murer L; Busolo F; Rigamonti W; Zanon GF; Zacchello G J Nephrol; 2003; 16(4):591-4. PubMed ID: 14696764 [TBL] [Abstract][Full Text] [Related]
14. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. Lowance D; Neumayer HH; Legendre CM; Squifflet JP; Kovarik J; Brennan PJ; Norman D; Mendez R; Keating MR; Coggon GL; Crisp A; Lee IC N Engl J Med; 1999 May; 340(19):1462-70. PubMed ID: 10320384 [TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection with multiple colonic perforations in a renal transplant recipient. De Bartolomeis C; Collini A; Barni R; Ruggieri G; Bernini M; Carmellini M Transplant Proc; 2005; 37(6):2504-6. PubMed ID: 16182726 [TBL] [Abstract][Full Text] [Related]
16. Delayed onset CMV disease in solid organ transplant recipients. Husain S; Pietrangeli CE; Zeevi A Transpl Immunol; 2009 May; 21(1):1-9. PubMed ID: 19162183 [TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus ureteritis as a cause of renal failure in a child infected with the human immunodeficiency virus. Mueller BU; MacKay K; Cheshire LB; Choyke PL; Kitchen B; Widemann B; Pizzo PA Clin Infect Dis; 1995 Apr; 20(4):1040-3. PubMed ID: 7795047 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients. Ahsan N; Holman MJ; Yang HC Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699 [TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus is a potential risk factor for late-onset hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation. Han TT; Xu LP; Liu DH; Liu KY; Fu HX; Zhao XY; Zhao XS; Huang XJ Am J Hematol; 2014 Jan; 89(1):55-61. PubMed ID: 24009106 [TBL] [Abstract][Full Text] [Related]
20. [The significance of risk-adapted antiviral prophylaxis and modern virus diagnosis for organ survival after kidney transplantation]. Fricke L; Steinhoff J; Hartwig-Weber I; Bein G Dtsch Med Wochenschr; 1997 May; 122(18):565-71. PubMed ID: 9190308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]